Aurinia Reports First Quarter 2021 Financial Results and Recent Operational Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Aurinia Pharmaceuticals (AUPH) Misses Q1 EPS by 26c
May 6, 2021 4:57 PM EDTAurinia Pharmaceuticals (NASDAQ: AUPH) reported Q1 EPS of ($0.40), $0.26 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $900 thousand versus the consensus estimate of $40 thousand.
For earnings history and earnings-related data on Aurinia Pharmaceuticals (AUPH) click here.
... More


